Hereditary pancreatic cancer: Molecular bases and their application in diagnosis and clinical management. A guideline of the TTD group

Clinical and Translational Oncology

Volumn 14, Issue 8, 2012, Pages 553-563

  Segura, P Pérez ^a   Ponce, C Guillén ^b   Ramon Y Cajal T ^c   Blanch, R Serrano ^d   Aranda, E ^d  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Familial pancreatic cancer; Screening; Susceptibility genes

Indexed keywords

BIOLOGICAL MARKER; CANCER ANTIGEN 19.9; UNCLASSIFIED DRUG;

ARTICLE; ATAXIA TELANGIECTASIA; AUTOSOMAL DOMINANT INHERITANCE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SCREENING; CANCER SUSCEPTIBILITY; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXOCRINE PANCREATIC ADENOCARCINOMA; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; FAMILY HISTORY; GENETIC PREDISPOSITION; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HEREDITARY PANCREATIC CANCER; HIGH RISK POPULATION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MUCINOUS CYSTIC NEOPLASM; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PANCREAS CANCER; PANCREATITIS; PEUTZ JEGHERS SYNDROME; RISK FACTOR; SURVIVAL RATE; TUBEROUS SCLEROSIS; VON HIPPEL LINDAU DISEASE;

CARCINOMA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MASS SCREENING; PANCREAS; PANCREATIC NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 84865729033     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0840-0     Document Type: Article

References (83)

1. Cabanes Domenech A, Pérez-Gómez B, Aragonés N et al (2009) La situación del cáncer en España, 1975-2006. http://www.isciii.es/htdocs/pdf/epicancerjunio2009.pdf
2. Anderson KE, Mack TM, Silverman D (2006) Cancer of the pancreas. In: Schottenfeld D, Fraumeni JJ (eds) Cancer epidemiology and prevention. Oxford University Press, New York
3. Permuth-Wey J, Egan KM (2009) Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer 8(2):109-117
4. Wang W, Chen S, Brune KA et al (2007) PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 25(11):1417-1422 (Pubitemid 46706891)
5. Wang L, Brune KA, Visvanathan K et al (2009) Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol Biomarkers Prev 18(11):2829-2834
6. Karnik SK, Hughes CM, Gu X et al (2005) Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA 102:14659-14664 (Pubitemid 41457112)
7. Giraud S, Zhang CX, Serova-Sinilnikova O et al (1998) Germline mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 63:455-467 (Pubitemid 30418627)
8. Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22-32
9. Trump D, Farren B, Wooding C et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 89:957-958
10. Carty SE, Helm AK, Amico JA et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124:1106-1114 (Pubitemid 28555202)
11. Shuin T, Yamasaki I, Tamura K et al (2006) Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol 36:337-343 (Pubitemid 44043921)
12. Charlesworth M, Verbeke CS, Falk GA et al (2012) Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. J Gastrointest Surg 16:1422-1428
13. Jensen RT, Berna MJ, Bingham DB, Norton JA (2008) Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113(7 Suppl):1807-1843
14. Ferner RE (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 6:340-351 (Pubitemid 46367948)
15. Miettinen M, Fetsch JF, Sobin LH et al (2006) Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 30:90-96 (Pubitemid 43740214)
16. Merritt JL, Davis DM, Pittelkow MR et al (2006) Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations. Am J Med Genet 140:1669-1672 (Pubitemid 44148255)
17. Hahn SA, Greenhalf B, Ellis I et al (2003) BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95(3):214-221 (Pubitemid 36240634)
18. Jones S, Hruban RH, Kamiyama M et al (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324(5924):217
19. Bartsch DK, Langer P, Habbe N et al (2010) Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families. Clin Genet 77(4):333-441
20. Hearle N, Schumacher V, Menko FH et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12(10):3209-3215 (Pubitemid 43837371)
21. Teich N, Mössner J (2008) Hereditary chronic pancreatitis. Best Pract Res Clin Gastroenterol 22(1):115-130
22. Habbe N, Langer P, Sina-Frey M, Bartsch DK (2006) Familial pancreatic cancer syndromes. Endocrinol Metab Clin North Am 35(2):417-430
23. Klapman J, Mokenge PM (2008) Early detection of pancreatic cancer: why, who and how to screen. Cancer Control 4(15):280-287
24. Tomlinson JS, Jain S, Bentrem DJ et al (2007) Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg 142:767-823
25. Fay MP, Pfeiffer R, Cronin KA et al (2003) Age-conditional probabilities of developing cancer. Stat Med 22:1837-1848 (Pubitemid 36603558)
26. Grocock CJ, Vitone LJ, Harcus MJ et al (2007) Familial pancreatic cancer: a review and latest advances. Adv Med Sci 52:37-50
27. Lochan R, Daly AK, Reeves HL, Charnley RM (2011) Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma. J Oncol ID 215985. doi:10.1155/2011/215985
28. Klein AP, Brune KA, Petersen GM et al (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64:2634-2638 (Pubitemid 38523922)
29. Giardello FM, Brensinger JD, Tersmette AC et al (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119:1447-1453 (Pubitemid 32198669)
30. Ferrone CR, Levine DA, Tang LH et al (2009) BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. J Clin Oncol 27(3):433-438
31. Real FX (2003) A "catastrophic hypothesis" for pancreas cancer progression. Gastroenterology 124:1958-1964 (Pubitemid 36666791)
32. Feldmann G, Beaty R, Hruban RH, Maitra A (2007) Molecular genetics of pancreatic intraepithelial neoplasias. J Hepatobiliary Pancreat Surg 14:224-232 (Pubitemid 46863910)
33. Ariyama J, Suyama M, Satoh K et al (1998) Imaging of small pancreatic ductal adenocarcinoma. Pancreas 16:396-401 (Pubitemid 28158047)
34. Brand RE, Lerch MM, Rubinstein WS et al (2007) Advances in counseling and surveillance of patients at risk for pancreatic cancer. Gut 56:1460-1469 (Pubitemid 47517845)
35. Canto MI, Goggins M, Hruban RH et al (2004) Screening for early pancreatic neoplasias in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2:606-621
36. Brentnall TA (2005) Management strategies for patients with hereditary pancreatic cancer. Curr Treat Options Oncol 6:437-445 (Pubitemid 41684223)
37. Shah M, Stadler Z, Canto M (2011) Genetic syndromes of upper gastrointestinal oncology for the medical oncologist: syndromes, testing, and screening. ASCO Educational Book, pp 130-135
38. Hruban RH, Adsay NV, Albores-Saavedra J et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 5(5):579-586 (Pubitemid 32423354)
39. Hruban RH, Takaori K, Klimstra DS et al (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28(8):977-987 (Pubitemid 38971421)
40. Shi C, Klein AP, Goggins M et al (2009) Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res 15(24): 7737-7743
41. Brune K, Abe T, Canto M et al (2006) Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 30(9):1067-1076 (Pubitemid 44299338)
42. Mino-Kenudson M, Fernández-del Castillo C, Baba Y et al (2011) Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. doi:10.1136/gut.2010.232272
43. Longnecker DS (2011) Pathology of exocrine pancreatic neoplasms. UptoDate, Inc
44. Klimstra DS, Pitman MB, Hruban RH (2009) An algorithmic approach to the diagnosis of pancreatic neoplasms. Arch Pathol Lab Med 133(3):454-464
45. Goh BK, Tan YM, Chung YF et al (2006) A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg 30(12):2236-2245 (Pubitemid 44885181)
46. Hruban RH, Pitman MB, Klimstra DS (2007) Tumors of the pancreas. In: Atlas of tumor pathology, Fascicle 6. Armed Forces Institute of Pathology, Washington, DC
47. (2010) Tumours of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system. IARC Press, Lyon
48. Crippa S, Salvia R, Warshaw AL et al (2008) Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 247(4):571-579 (Pubitemid 351440607)
49. Hemminki K, Li X (2003) Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 103:525-530 (Pubitemid 36020229)
50. Rutter JL, Bromley CM, Goldstein AM et al (2004) Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. Cancer 101(12):2809-2816 (Pubitemid 39603189)
51. McWilliams RR, Wieben ED, Rabe KG et al (2011) Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling. Eur J Hum Genet 19(4):472-478
52. Whitcomb DC, Gorry MC, Preston RA et al (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14(2):141-145 (Pubitemid 26338792)
53. Rebours V, Boutron-Ruault MC, Schnee M et al (2008) Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 103(1):111-119
54. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ et al (2005) Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 42(9):711-719 (Pubitemid 41306062)
55. Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98(23):1694-1706 (Pubitemid 44942707)
56. DiMagno EP, Reber HA, Tempero MA (1999) AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 117:1464-1484
57. Brentnall TA (2011) Pancreatic cancer surveillance: learning as we go. Am J Gastroenterol 106(5):955-956
58. Hruban RH, Canto M, Goggins M, Schulick R, Klein A (2010) Update on familial pancreatic cancer. Adv Surg 44:293-311
59. Canto MI, Goggins M, Hruban RH et al (2006) Screening for early pancreatic neoplasias in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 4:766-781 (Pubitemid 43825802)
60. Poley JW, Kluijt I, Gouma DJ et al (2009) The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 104:2175-2181
61. Langer P, Kann PH, Fendrich V et al (2009) Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 58:1410-1418
62. Kim JE, Lee KT, Lee JK et al (2004) Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 19(2):182-186 (Pubitemid 38253358)
63. Malesci A, Montorsi M, Mariani A et al (1992) Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study. Pancreas 7(4):497-502
64. Riker A, Libutti SK, Bartlett DL (1997) Advances in the early detection, diagnosis, and staging of pancreatic cancer. Surg Oncol 6:157-169 (Pubitemid 28119140)
65. Brentnall TA, Bronner MP, Byrd DR et al (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131:247-255 (Pubitemid 29383653)
66. Homma T, Tsuchiya R (1991) The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19-9 and elastase-1 or ultrasonography. Int J Pancreatol 9:119-124
67. Gullo L, Migliori M, Fusaroli P, Caletti G (2007) Familial association of benign pancreatic hyperenzymaemia and pancreatic cancer. Gut 56:1323-1324 (Pubitemid 47300440)
68. Lynch HT, Deters CA, Lynch JF, Brand RE (2004) Familial pancreatic carcinoma in Jews. Fam Cancer 3:233-240
69. Yan L, McFaul C, Howes N et al (2005) Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. Gastroenterology 128:2124-2130 (Pubitemid 40824719)
70. Parsi MA, Li A, Li CP, Goggins M (2008) DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease. Clin Gastroenterol Hepatol 6(11): 1270-1278
71. Matsubayashi H, Canto M, Sato N et al (2006) DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 66(2):1208-1217 (Pubitemid 43165992)
72. Goldstein AM, Fraser MC, Struewing JP et al (1995) Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 333:970-974
73. Aimoto T, Uchida E, Nakamura Y et al (2008) Multicentric pancreatic intraepithelial neoplasias (PanINs) presenting with the clinical features of chronic pancreatitis. J Hepatobiliary Pancreat Surg 15(5):549-553
74. Rulyak SJ, Kimmey MB, Veenstra DL, Brentnall TA (2003) Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 57:23-29 (Pubitemid 36236794)
75. Varadarajulu S, Tamhane A, Eloubeidi MA (2005) Yield of EUS guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 62:728-736 (Pubitemid 41503000)
76. Brand R (2001) The diagnosis of pancreatic cancer. Cancer J 7:287-297
77. Balci NC, Semelka RC (2001) Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Eur J Radiol 38:105-112 (Pubitemid 32396818)
78. Megibow AJ, Zhou XH, Rotterdam H et al (1995) Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability-report of the Radiology Diagnostic Oncology Group. Radiology 195:327-332
79. Vasen HF, Wasser M, van Mil A et al (2011) Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 140(3):850-856
80. Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B (1994) Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 190:745-751 (Pubitemid 24071041)
81. Kimmey MB, Bronner MR, Byrd DR, Brentnall TA (2002) Screening and surveillance for hereditary pancreatic cancer. Gastrointestinal Endosc 56:S82-S86
82. Bartsch DK, Sina-Frey M, Ziegler A et al (2001) Update of familial pancreatic cancer in Germany. Pancreatology 1:510-516 (Pubitemid 33681753)
83. Applebaum SE, Kant JA, Whitcomb DC et al (2000) Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med Clin North Am 84:575-588 (Pubitemid 30346153)